Prot# LBSL02: A Phs 2, Mlti-Cntr, Dbl-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, & Efficacy of LymphoStat-B? Antibody (Monoclonal Anti-BLyS Antibody) in Subjects w/Systemic Lupus Erythematosus (SLE)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/14/038/21/10

Funding

  • Human Genome Sciences, Inc. (LBSL02)